Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing multiple small-molecule programs for autoimmune, ...
The parasite that may already live in your brain can infect the very immune cells trying to destroy it, but new UVA Health research reveals how our bodies keep it under control.
Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of small cell lung cancer. Small cell lung cancer (SCLC) is among the most ...
News Medical on MSN
Inflammation and immune suppression fuel aggressive SCLC behavior and spread
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only five percent. Despite this poor prognosis, SCLC is initially highly responsive ...
Les caspases (de l'anglais cysteinyl-aspartate-cleaving proteases) sont un groupe de protéases à cystéine. Elles sont présentes dans le cytoplasme sous forme inactive: les procaspases. Les procaspases ...
Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year survival rate of only five percent. Despite this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback